Seeing Is Believing
Currently out of the existing stock ratings of Mohit Bansal, 141 are a BUY (62.39%), 81 are a HOLD (35.84%), 4 are a SELL (1.77%).
Analyst Mohit Bansal, currently employed at WELLS FARGO, carries an average stock price target met ratio of 66.61% that have a potential upside of 27.27% achieved within 199 days.
Mohit Bansal’s has documented 445 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 06-Aug-2025.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $115 was fulfilled within 1 day with a profit of $19 (19.79%) receiving and performance score of 197.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$51
$12.2 (31.44%)
$71
1 months 1 days ago
(22-Jul-2025)
6/9 (66.67%)
$11.34 (28.59%)
477
Buy
$57
$18.2 (46.91%)
$55
8 months 13 days ago
(10-Dec-2024)
5/6 (83.33%)
$10.98 (23.86%)
84
Buy
$51
$12.2 (31.44%)
10 months 13 days ago
(10-Oct-2024)
1/1 (100%)
$9.18 (21.95%)
27
Hold
$56
$17.2 (44.33%)
$61
10 months 27 days ago
(27-Sep-2024)
10/13 (76.92%)
$10.39 (22.78%)
223
Hold
$46
$7.2 (18.56%)
$30
1 years 2 months 10 days ago
(13-Jun-2024)
4/4 (100%)
$-0.77 (-1.65%)
169
Which stock is Mohit Bansal is most bullish on?
Which stock is Mohit Bansal is most reserved on?
What Year was the first public recommendation made by Mohit Bansal?